In a filing, Bio-Techne Corp revealed its Director Herr Amy E. unloaded Company’s shares for reported $0.12 million on Feb 14 ’25. In the deal valued at $65.96 per share,1,860 shares were sold. As a result of this transaction, Herr Amy E. now holds 1,976 shares worth roughly $97377.28.
Then, JOSHUA MOLHO bought 1,860 shares, generating $122,691 in total proceeds.
Before that, Kelderman Kim sold 13,392 shares. Bio-Techne Corp shares valued at $1,035,013 were divested by the Chief Executive Officer at a price of $77.29 per share. As a result of the transaction, Kelderman Kim now holds 39,004 shares, worth roughly $1.92 million.
KeyBanc Capital Markets downgraded its Bio-Techne Corp [TECH] rating to a Sector weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who began to cover the stock in mid March with a ‘”an Outperform”‘ rating. Robert W. Baird also remained covering TECH and has decreased its forecast on February 19, 2025 with a “Neutral” recommendation from previously “an Outperform” rating. Citigroup revised its rating on May 22, 2024. It rated TECH as “a Neutral” which previously was an “a Buy”.
Price Performance Review of TECH
On Monday, Bio-Techne Corp [NASDAQ:TECH] saw its stock jump 0.26% to $49.28. Over the last five days, the stock has lost -8.57%. Bio-Techne Corp shares have fallen nearly -31.58% since the year began. Nevertheless, the stocks have fallen -40.98% over the past one year.
How much short interest is there in Bio-Techne Corp?
A steep rise in short interest was recorded in Bio-Techne Corp stocks on 2025-04-30, growing by 0.43 million shares to a total of 6.48 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 6.05 million shares. There was a rise of 6.64%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 08, 2024 when Scotiabank began covering the stock and recommended ‘”a Sector outperform”‘ rating along with a $80 price target.
